Sarah H O Brien

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Sarah H. O’Brien

Biography

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Patient Care

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hemostasis and Thrombosis Center

Physician Team

Center for Child Health Equity and Outcomes Research

Principal Investigator

Hematology, Oncology and BMT Fellowship

Faculty

Pediatric Hemostasis-Thrombosis Fellowship

Faculty

Patient-Centered Pediatric Research Program

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Awards, Honors & Organizations

Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013 AAMC Early Career Women Faculty Professional Development Seminar, 2012 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009 Career Development Award, Hemophilia and Thrombosis Research Society, 2007 Fellow Scholar Award, American Society of Hematology, 2006 Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006 Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003 Primary Care Award, Children’s Hospital of Pittsburgh, 2003 Research Award, Region III Ambulatory Pediatric Association, 2002 Listed, Best Doctors in America Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014 Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present Member, American Society of Pediatric Hematology/Oncology, 2004 - Present Member, Hemophilia and Thrombosis Research Society, 2004 - Present Member, American Society of Hematology, 2003 - Present Member, Children’s Oncology Group, 2001 - Present Member, Alpha Omega Alpha, 2000 - Present

Research

Lab(s)

Center for Child Health Equity and Outcomes Research

Publications

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

Professional Experience

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics2013 - Present Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Associate Professor2006 - Present Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital, Investigator2006 - 2013 Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Assistant Professor2003 - 2006 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship2000 - 2003 Children’s Hospital of Pittsburgh, Pediatric Residency

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Sarah H. O’Brien

Biography

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Patient Care

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hemostasis and Thrombosis Center

Physician Team

Center for Child Health Equity and Outcomes Research

Principal Investigator

Hematology, Oncology and BMT Fellowship

Faculty

Pediatric Hemostasis-Thrombosis Fellowship

Faculty

Patient-Centered Pediatric Research Program

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Awards, Honors & Organizations

Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013 AAMC Early Career Women Faculty Professional Development Seminar, 2012 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009 Career Development Award, Hemophilia and Thrombosis Research Society, 2007 Fellow Scholar Award, American Society of Hematology, 2006 Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006 Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003 Primary Care Award, Children’s Hospital of Pittsburgh, 2003 Research Award, Region III Ambulatory Pediatric Association, 2002 Listed, Best Doctors in America Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014 Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present Member, American Society of Pediatric Hematology/Oncology, 2004 - Present Member, Hemophilia and Thrombosis Research Society, 2004 - Present Member, American Society of Hematology, 2003 - Present Member, Children’s Oncology Group, 2001 - Present Member, Alpha Omega Alpha, 2000 - Present

Research

Lab(s)

Center for Child Health Equity and Outcomes Research

Publications

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

Professional Experience

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics2013 - Present Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Associate Professor2006 - Present Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital, Investigator2006 - 2013 Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Assistant Professor2003 - 2006 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship2000 - 2003 Children’s Hospital of Pittsburgh, Pediatric Residency

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Sarah H. O’Brien

Contact Information

• Call us at:
• (614) 722-3550
• Fax us at:
• (614) 722-3369
• PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Sarah H. O’Brien

Biography

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Biography

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Biography

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Dr. O’Brien’s clinical and research interests include pediatric thrombosis and thromboprophylaxis, the evaluation and diagnosis of mild bleeding disorders, and the intersections between hematology and women’s health. She also leads a multidisciplinary hematology and adolescent gynecology clinic at Nationwide Children’s. As a health services researcher, Dr. O’Brien has a particular interest in the use of large administrative databases, as well as decision analysis and cost effectiveness analysis. She attended the University of Pittsburgh School of Medicine and received her residency and fellowship training from Children’s Hospital of Pittsburgh of UPMC. Dr. O’Brien is voted among the Best Doctors in America.

Patient Care

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

Locations

Dublin Close To Home Center at 5675 Venture Drive

Main Campus of Nationwide Children’s Hospital

• Dublin Close To Home Center at 5675 Venture Drive
• Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hemostasis and Thrombosis Center

Physician Team

Center for Child Health Equity and Outcomes Research

Principal Investigator

Hematology, Oncology and BMT Fellowship

Faculty

Pediatric Hemostasis-Thrombosis Fellowship

Faculty

Patient-Centered Pediatric Research Program

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hemostasis and Thrombosis Center

Physician Team

Center for Child Health Equity and Outcomes Research

Principal Investigator

Hematology, Oncology and BMT Fellowship

Faculty

Pediatric Hemostasis-Thrombosis Fellowship

Faculty

Patient-Centered Pediatric Research Program

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Hemostasis and Thrombosis Center

Physician Team

Center for Child Health Equity and Outcomes Research

Principal Investigator

Hematology, Oncology and BMT Fellowship

Faculty

Pediatric Hemostasis-Thrombosis Fellowship

Faculty

Patient-Centered Pediatric Research Program

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Hematology/Oncology & BMT

Physician Team

Hemostasis and Thrombosis Center

Physician Team

Center for Child Health Equity and Outcomes Research

Principal Investigator

Hematology, Oncology and BMT Fellowship

Faculty

Pediatric Hemostasis-Thrombosis Fellowship

Faculty

Patient-Centered Pediatric Research Program

Faculty

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

• Hematology/Oncology & BMT
• Physician Team
• Hemostasis and Thrombosis Center
• Physician Team
• Center for Child Health Equity and Outcomes Research
• Principal Investigator
• Hematology, Oncology and BMT Fellowship
• Faculty
• Pediatric Hemostasis-Thrombosis Fellowship
• Faculty
• Patient-Centered Pediatric Research Program
• Faculty
• Primary Department
• Pediatrics
• Primary Section
• Hematology & Oncology

Awards, Honors & Organizations

Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013 AAMC Early Career Women Faculty Professional Development Seminar, 2012 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009 Career Development Award, Hemophilia and Thrombosis Research Society, 2007 Fellow Scholar Award, American Society of Hematology, 2006 Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006 Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003 Primary Care Award, Children’s Hospital of Pittsburgh, 2003 Research Award, Region III Ambulatory Pediatric Association, 2002 Listed, Best Doctors in America Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014 Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present Member, American Society of Pediatric Hematology/Oncology, 2004 - Present Member, Hemophilia and Thrombosis Research Society, 2004 - Present Member, American Society of Hematology, 2003 - Present Member, Children’s Oncology Group, 2001 - Present Member, Alpha Omega Alpha, 2000 - Present

Awards, Honors & Organizations

Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013 AAMC Early Career Women Faculty Professional Development Seminar, 2012 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009 Career Development Award, Hemophilia and Thrombosis Research Society, 2007 Fellow Scholar Award, American Society of Hematology, 2006 Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006 Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003 Primary Care Award, Children’s Hospital of Pittsburgh, 2003 Research Award, Region III Ambulatory Pediatric Association, 2002 Listed, Best Doctors in America Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014 Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present Member, American Society of Pediatric Hematology/Oncology, 2004 - Present Member, Hemophilia and Thrombosis Research Society, 2004 - Present Member, American Society of Hematology, 2003 - Present Member, Children’s Oncology Group, 2001 - Present Member, Alpha Omega Alpha, 2000 - Present

Awards, Honors & Organizations

Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013 AAMC Early Career Women Faculty Professional Development Seminar, 2012 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009 Career Development Award, Hemophilia and Thrombosis Research Society, 2007 Fellow Scholar Award, American Society of Hematology, 2006 Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006 Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003 Primary Care Award, Children’s Hospital of Pittsburgh, 2003 Research Award, Region III Ambulatory Pediatric Association, 2002 Listed, Best Doctors in America Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014 Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present Member, American Society of Pediatric Hematology/Oncology, 2004 - Present Member, Hemophilia and Thrombosis Research Society, 2004 - Present Member, American Society of Hematology, 2003 - Present Member, Children’s Oncology Group, 2001 - Present Member, Alpha Omega Alpha, 2000 - Present

Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013 AAMC Early Career Women Faculty Professional Development Seminar, 2012 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011 Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009 Career Development Award, Hemophilia and Thrombosis Research Society, 2007 Fellow Scholar Award, American Society of Hematology, 2006 Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006 Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004 Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003 Primary Care Award, Children’s Hospital of Pittsburgh, 2003 Research Award, Region III Ambulatory Pediatric Association, 2002 Listed, Best Doctors in America Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014 Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present Member, American Society of Pediatric Hematology/Oncology, 2004 - Present Member, Hemophilia and Thrombosis Research Society, 2004 - Present Member, American Society of Hematology, 2003 - Present Member, Children’s Oncology Group, 2001 - Present Member, Alpha Omega Alpha, 2000 - Present

• Eberhard Mammen Excellence in Thrombosis and Hemostasis Award - Young Investigator, 2013
• AAMC Early Career Women Faculty Professional Development Seminar, 2012
• Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2011
• Loan Repayment Program Renewal, National Institutes of Health Pediatric Research, 2009
• Career Development Award, Hemophilia and Thrombosis Research Society, 2007
• Fellow Scholar Award, American Society of Hematology, 2006
• Scholar (Awarded to the Recipient of an ASH Scholar Award with the Highest Scored Clinical/Translational Research Application), Wallace H. Coulter Foundation, 2006
• Clinical Thrombosis Research Award, Hemophilia and Thrombosis Research Society, 2004
• Mark A. Sperling Resident Research Award, Children’s Hospital of Pittsburgh, 2003
• Primary Care Award, Children’s Hospital of Pittsburgh, 2003
• Research Award, Region III Ambulatory Pediatric Association, 2002
• Listed, Best Doctors in America
• Member, Faculty Leadership Institute, The Ohio State University Wexner Medical Center, 2013 - 2014
• Member, American Society of Hematology Clinical Research Training Institute, 2005 - Present
• Member, American Society of Pediatric Hematology/Oncology, 2004 - Present
• Member, Hemophilia and Thrombosis Research Society, 2004 - Present
• Member, American Society of Hematology, 2003 - Present
• Member, Children’s Oncology Group, 2001 - Present
• Member, Alpha Omega Alpha, 2000 - Present

Research

Lab(s)

Center for Child Health Equity and Outcomes Research

Publications

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Research

Lab(s)

Center for Child Health Equity and Outcomes Research

Publications

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Research

Lab(s)

Center for Child Health Equity and Outcomes Research

Publications

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Lab(s)

Center for Child Health Equity and Outcomes Research

Publications

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Lab(s)

Center for Child Health Equity and Outcomes Research

                  O'Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

                


                  Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O'Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

                


                  O'Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

                


                  O'Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25;  1-20.

                


                  Male C, O'Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

                


                  Powers JM, O'Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

                


                  Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O'Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

                


                  O'Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;  

                


                  Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O'Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;  

                


                  O'Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;  

                


                  Male C, Thom K, O'Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;  

                


                  Jacobson AE, Vesely SK, Koch T, Campbell J, O'Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

View More Publications

Lab(s)

Center for Child Health Equity and Outcomes Research

• Center for Child Health Equity and Outcomes Research

• O’Brien SH, Saini S. von Willebrand Disease in Pediatrics: Evaluation and Management. Hematol Oncol Clin North Am. 2019 Jun; 33: 425-438.

• Saini S, Folta AN, Harsh KL, Stanek JR, Dunn AL, O’Brien SH, Kumar R. Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort. J Pediatr. 2019 Jun; 209: 212-219.e1.

• O’Brien SH, Li D, Mitchell LG, Hess T, Zee P, Yee DL, Newburger JW, Sung L, Rodriguez V. PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost. 2019 May; 119: 844-853.

• O’Brien S, Metcalf K, Batchelor J. An examination of the heterogeneity of cognitive outcome following severe to extremely severe traumatic brain injury. Clin Neuropsychol. 2019 Apr 25; 1-20.

• Male C, O’Brien SH, Mitchell L. THROMBOTECT takes the lead. Haematologica. 2019 Apr; 104: 644-645.

• Powers JM, O’Brien SH. How I approach iron deficiency with and without anemia. Pediatr Blood Cancer. 2019 Mar; 66: e27544.

• O’Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Hematology Am Soc Hematol Educ Program. 2018 Nov 30; 2018: 390-398.

• Monagle P, Cuello CA, Augustine C, Bonduel M, Brandão LR, Capman T, Chan AKC, Hanson S, Male C, Meerpohl J, Newall F, O’Brien SH, Raffini L, van Ommen H, Wiernikowski J, Williams S, Bhatt M, Riva JJ, Roldan Y, Schwab N, Mustafa RA, Vesely SK. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27; 2: 3292-3316.

• O’Brien SH. Evaluation and management of heavy menstrual bleeding in adolescents: the role of the hematologist. Blood. 2018 Nov 14;

• Zia A, Stanek J, Christian-Rancy M, Ahuja SP, Savelli S, O’Brien SH. Utility of a screening tool for haemostatic defects in a multicentre cohort of adolescents with heavy menstrual bleeding. Haemophilia. 2018 Sep 12;

• O’Brien SH, Despotovic JM, Neunert CE. Intravenous Immunoglobulin Versus Anti-D Immunoglobulin: When Better Treatment May Not Be the Best Treatment. J Pediatr. 2018 Sep 28;

• Male C, Thom K, O’Brien SH. Direct oral anticoagulants: What will be their role in children? Thromb Res. 2018 Jun 28;

• Jacobson AE, Vesely SK, Koch T, Campbell J, O’Brien SH. Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding. Obstet Gynecol. 2018 Jun; 131: 1121-1129.

Education

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

Education

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

Education

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

Date of Appointment at Nationwide Children’s Hospital: 09/29/2006

Board Certifications

Pediatric Hematology Oncology

Fellowship

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 07/31/2006

Residency

Children’s Hospital of Pittsburgh of UPMC

Date Completed: 06/30/2003

Medical School

University of Pittsburgh School of Medicine

Date Completed: 05/31/2000

• Pediatric Hematology Oncology

Professional Experience

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics2013 - Present Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Associate Professor2006 - Present Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital, Investigator2006 - 2013 Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Assistant Professor2003 - 2006 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship2000 - 2003 Children’s Hospital of Pittsburgh, Pediatric Residency

Professional Experience

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics2013 - Present Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Associate Professor2006 - Present Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital, Investigator2006 - 2013 Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Assistant Professor2003 - 2006 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship2000 - 2003 Children’s Hospital of Pittsburgh, Pediatric Residency

Professional Experience

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics2013 - Present Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Associate Professor2006 - Present Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital, Investigator2006 - 2013 Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Assistant Professor2003 - 2006 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship2000 - 2003 Children’s Hospital of Pittsburgh, Pediatric Residency

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics2013 - Present Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Associate Professor2006 - Present Center for Innovation in Pediatric Practice, The Research Institute at Nationwide Children’s Hospital, Investigator2006 - 2013 Pediatric Hematology/Oncology, The Ohio State University College of Medicine, Assistant Professor2003 - 2006 Children’s Hospital of Pittsburgh, Pediatric Hematology/Oncology Fellowship2000 - 2003 Children’s Hospital of Pittsburgh, Pediatric Residency

2013 - Present Section of Hematology/Oncology/BMT, Nationwide Children’s Hospital, Director of Experimental Therapeutics

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-3550
• Fax us at:
• (614) 722-3369
• Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)